Media

May 19, 2026 All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, May 19, 2026 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCPK: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that, as approved by the TSX Venture

March 2, 2026 Achieves Positive Adjusted EBITDA All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, March 2, 2026 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCPK: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried

April 17, 2026 All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, April 17, 2026 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCPK: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and food and

March 17, 2026 All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, March 17, 2026 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCPK: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis

February 17, 2026 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, February 17, 2026 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCPK: PCLOF), the

December 30, 2025 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, December 30, 2025 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCPK: PCLOF), the

October 6, 2025 All amounts expressed in Canadian dollars unless otherwise noted TORONTO, Canada and RIONEGRO, Colombia (October 6th, 2025) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTC: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade

August 6, 2025 All figures in Canadian dollars ($) unless otherwise specified TORONTO, Canada and RIONEGRO, Colombia (August 6, 2025) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTC: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade

February 28, 2025 PharmaCielo achieved 143% Year-Over-Year Sales Growth, Generating Year-to-Date Q4 Total Revenue of $3.54 Million Revenues and Gross Profit Margin Increased with More Diverse Customer Base Q4 Cash Flow Continued to Improve and Adjusted EBITDA Increased by $1.1 Million versus Last Year Reflecting

February 12, 2025 All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, February 12, 2025 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTC: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis